Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis.
Although simple steatosis was originally thought to be a pathologically inert histological change, fat accumulation in the liver may play a critical role not only in disease initiation, but also in the progression to nonalcoholic steatohepatitis and cirrhosis. Therefore, prevention of fat accumulation in the liver may be an effective therapy for multiple stages of nonalcoholic fatty liver disease (NAFLD). Promising beneficial effects of betaine supplementation on human NAFLD have been reported in some pilot clinical studies; however, data related to betaine therapy in NAFLD are limited. In this study, we examined the effects of betaine on fat accumulation in the liver induced by high-sucrose diet and evaluated mechanisms by which betaine could attenuate or prevent hepatic steatosis in this model. Male C57BL/6 mice weighing 20 +/- 0.5 g (means +/- SE) were divided into four groups (8 mice per group) and started on one of four treatments: standard diet (SD), SD+betaine, high-sucrose diet (HS), and HS + betaine. Betaine was supplemented in the drinking water at a concentration of 1% (wt/vol) (anhydrous). Long-term feeding of high-sucrose diet to mice caused significant hepatic steatosis accompanied by markedly increased lipogenic activity. Betaine significantly attenuated hepatic steatosis in this animal model, and this change was associated with increased activation of hepatic AMP-activated protein kinase (AMPK) and attenuated lipogenic capability (enzyme activities and gene expression) in the liver. Our findings are the first to suggest that betaine might serve as a therapeutic tool to attenuate hepatic steatosis by targeting the hepatic AMPK system.
Song
Zhenyuan
Z
Dept. of Medicine, Univ. of Louisville Medical Center, Louisville, KY 40292, USA. z0song02@louisville.edu
Deaciuc
Ion
I
Zhou
Zhanxiang
Z
Song
Ming
M
Chen
Theresa
T
Hill
Daniell
D
McClain
Craig J
CJ
D055372:AMP-Activated Protein Kinases; D000103:Acetyl-CoA Carboxylase / Q000378:metabolism; D000818:Animals; D001622:Betaine / Q000627:therapeutic use*; D002460:Cell Line; D004040:Dietary Carbohydrates / Q000008:administration & dosage*; D004195:Disease Models, Animal; D005234:Fatty Liver / Q000188:drug therapy*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009097:Multienzyme Complexes / Q000502:physiology*; D017346:Protein Serine-Threonine Kinases / Q000502:physiology*; D013395:Sucrose / Q000008:administration & dosage*
D004040:Dietary Carbohydrates; D009097:Multienzyme Complexes; D001622:Betaine; D013395:Sucrose; D017346:Protein Serine-Threonine Kinases; D055372:AMP-Activated Protein Kinases; D000103:Acetyl-CoA Carboxylase
Diabetes Obes Metab. 2006 May;8(3):264-80
16634986
Biochimie. 2005 Jan;87(1):87-91
15733742
J Clin Invest. 2006 Jul;116(7):1776-83
16823475
Biochim Biophys Acta. 2000 Jun 26;1486(1):1-17
10856709
Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10072-7
12122204
Hepatology. 1995 Dec;22(6):1714-9
7489979
Semin Liver Dis. 2004 Feb;24(1):99-106
15085490
Alcohol Clin Exp Res. 1997 Sep;21(6):1100-2
9309323
Hepatology. 2002 Oct;36(4 Pt 1):829-39
12297830
Semin Liver Dis. 2001;21(1):89-104
11296700
Mol Cell Biochem. 2003 Nov;253(1-2):65-70
14619957
Biochem Soc Trans. 2003 Feb;31(Pt 1):220-3
12546689
J Clin Invest. 2003 Jul;112(1):91-100
12840063
Am J Clin Nutr. 2004 Sep;80(3):539-49
15321791
J Hepatol. 2007 Feb;46(2):314-21
17156888
Mayo Clin Proc. 1980 Jul;55(7):434-8
7382552
Hepatology. 2004 Oct;40(4):989-97
15382170
J Biol Chem. 2004 Nov 12;279(46):47898-905
15371448
Diabetes. 2005 May;54(5):1331-9
15855317
J Clin Invest. 2001 Oct;108(8):1167-74
11602624
N Engl J Med. 2000 Nov 16;343(20):1467-76
11078773
Am J Gastroenterol. 2001 Sep;96(9):2711-7
11569700
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2557-62
9122234
J Hepatol. 1998 Sep;29(3):495-501
9765002
Clin Liver Dis. 2004 Aug;8(3):575-94, ix
15331065
J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S17-29
16540762
Gastroenterology. 2003 May;124(5):1488-99
12730887
Can J Biochem Physiol. 1959 Aug;37(8):911-7
13671378
J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S61-6
16540770
Biochem Pharmacol. 2005 Dec 5;70(12):1883-90
16253211
Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E175-81
16464908
J Biol Chem. 2002 Sep 6;277(36):32571-7
12065578
J Hepatol. 2003 Dec;39(6):978-83
14642615
Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G1-6
15194557
Arterioscler Thromb Vasc Biol. 2006 May;26(5):1043-50
16497994
Arzneimittelforschung. 2000 Aug;50(8):722-7
10994156
J Biol Chem. 2002 Feb 8;277(6):3829-35
11724780
J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S186-90
12000605
Am J Physiol Gastrointest Liver Physiol. 2000 Jul;279(1):G178-85
10898761